Investors

Overview

Havn Life is focused on the rapidly growing field of psychedelic medicine. We have the opportunity to lead the standardization of psychedelic supply to shift human performance & mental health paradigms. 

Our Team

Collaboration across disciplines

Creating positive patient experiences and mental health outcomes

Vic Neufeld

Executive Chairman

CEO of Aphria for 5 years during large scale build up to one of the leading cannabis producers in the world.

Tim Moore

Chief Executive Officer

Former CEO of Green Growth Brands, from IPO through to Jan 2019, leading the Company to ~$1 Billion market cap.

Susan Chapelle

Executive Vice-President, Research & Development

Recognized thought leader in the Canadian Cannabis space. 25 years of leadership experience in healthcare, non-profit, and private sectors in Canada.

Gary Leong

Chief Scientific Officer

Former Chief Scientific Officer at Aphria Inc. where he established and oversaw the Quality Assurance, Quality Control, Regulatory Affairs & Research and Development functions.

Dr. Ivan Casselman

Chief Psychedelic Officer

Extensive nutraceutical formulation experience, with several products available in legal cannabis markets in North America.

Alexzander Samuelsson

Chief Research Officer

Lead chemist of a publicly traded extraction company, Alexzander developed intellectual property and patented methods in the extraction of cannabis oils.

Eli Dusenbury

Chief Financial Officer

Served as a consultant for audit and public practice firms in both Canada and the US and has held CFO positions for publicly traded companies.

Juliana Mollica

Director of Innovation and Quality Assurance

Led projects as the quality assurance and compliance manager for cannabis and pharmaceutical companies to ensure maintenance of GMP requirements, developing QMS for multi-site projects, compliance training programs, and increasing compliance and quality rates.

Rick Brar

Vice Chairman

CEO & Chairman of Brains Bioceutical Corp. A global manufacturer and distributor of Cannabinoid API.

Barinder Rasode

President

Served two terms as elected Councilor for the City of Surrey. Served on the Board of BC’s largest health authority, Fraser Health, where she was responsible for a budget over $3 Billion.

Tim Laidler

Director

Executive Director of the Institute for Veterans Education and Transition at UBC. The institute focuses on supporting the needs of veterans in the community as well as supporting cutting edge research with Veterans.

Sheila Copps

Advisor

The Honourable Sheila Copps was the first woman to ever hold the position of Deputy Prime Minister and served for ten years in the federal cabinet.

Allan Oberman

Advisor

Served as CEO for Concordia International, an international speciality pharmaceutical company with sales in 90 countries and over 200 medicines.

Dr. David Mokler

Advisor

Expert specialist in neuropharmacology, psychopharmacology, substance abuse, drug abuse, brain development, dopamine and serotonin including work relevant to the 5HT2a receptors in psychedelics

Consultants

Legal Counsel

Auditor

De Visser Gray LLP
devissergray.com

Transfer Agent

Odyssey Trust Company
odysseytrust.com

CORPORATE PRESENTATION

CONTACT INVESTOR RELATIONS

Scroll to Top